<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 25 Aug 2026 08:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.</title>
   <link>http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;Dr. Thaïs Aliabadi, a board-certified OB-GYN and co-host of the SHE MD podcast, makes the case that preterm birth risk is personal, knowable between weeks 18 and 21 of pregnancy, and worth a direct conversation with your doctor. She points to a simple blood test, the PreTRM® Test from &lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics&lt;/span&gt;, and PRIME trial results showing early, low-cost intervention can cut the earliest preterm births by more than half.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt; and &lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 25, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- Preterm birth affects about 1 in 10 U.S. pregnancies.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/1+in+10+U.S.+Babies+Are+Born+Too+Early.+A+Leading+OB-GYN+Says+Most+Mothers+Can+Learn+Their+Risk+by+Week+21%2C+and+Do+Something+About+It./26971049.html</guid>
   <pubDate>Tue, 25 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.11693266</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20935137</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Form  8-K        SERA PROGNOSTICS, INC.    For: Aug 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Aug+14/26951017.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26951017.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Aug+14/26951017.html</guid>
   <pubDate>Wed, 19 Aug 2026 17:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Form  8-K        SERA PROGNOSTICS, INC.    For: Aug 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Aug+14/26951017.html</link>
   <description>si-local-file:///var/storage/secattach/20260819/26951017.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Aug+14/26951017.html</guid>
   <pubDate>Wed, 19 Aug 2026 17:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Sera Prognostics names Scott Gleason as CFO, effective Aug. 31</title>
   <link>http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</link>
   <description>

&lt;p&gt;Sera Prognostics Inc. (Nasdaq: SERA) announced the appointment of Scott Gleason as Chief Financial Officer, effective August 31, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Gleason brings more than 25 years of experience in healthcare, diagnostics, and capital markets. He most recently served as Vice President of Investor Relations and Treasury at Neogen Corporation. He previously held CFO roles at LarmorBio and NX Prenatal, served as interim CFO at OraSure Technologies, and led corporate strategy and investor relations at Myriad Genetics. He holds a B.S. in Economics from the United States Air Force Academy.&lt;/p&gt;

&lt;p&gt;&quot;Scott brings financial leadership, operating discipline, and capital markets</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Sera Prognostics names Scott Gleason as CFO, effective Aug. 31</title>
   <link>http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</link>
   <description>

&lt;p&gt;Sera Prognostics Inc. (Nasdaq: SERA) announced the appointment of Scott Gleason as Chief Financial Officer, effective August 31, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Gleason brings more than 25 years of experience in healthcare, diagnostics, and capital markets. He most recently served as Vice President of Investor Relations and Treasury at Neogen Corporation. He previously held CFO roles at LarmorBio and NX Prenatal, served as interim CFO at OraSure Technologies, and led corporate strategy and investor relations at Myriad Genetics. He holds a B.S. in Economics from the United States Air Force Academy.&lt;/p&gt;

&lt;p&gt;&quot;Scott brings financial leadership, operating discipline, and capital markets</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Sera Prognostics names Scott Gleason as CFO, effective Aug. 31</title>
   <link>http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</link>
   <description>

&lt;p&gt;Sera Prognostics Inc. (Nasdaq: SERA) announced the appointment of Scott Gleason as Chief Financial Officer, effective August 31, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Gleason brings more than 25 years of experience in healthcare, diagnostics, and capital markets. He most recently served as Vice President of Investor Relations and Treasury at Neogen Corporation. He previously held CFO roles at LarmorBio and NX Prenatal, served as interim CFO at OraSure Technologies, and led corporate strategy and investor relations at Myriad Genetics. He holds a B.S. in Economics from the United States Air Force Academy.&lt;/p&gt;

&lt;p&gt;&quot;Scott brings financial leadership, operating discipline, and capital markets</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Sera Prognostics names Scott Gleason as CFO, effective Aug. 31</title>
   <link>http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</link>
   <description>

&lt;p&gt;Sera Prognostics Inc. (Nasdaq: SERA) announced the appointment of Scott Gleason as Chief Financial Officer, effective August 31, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Gleason brings more than 25 years of experience in healthcare, diagnostics, and capital markets. He most recently served as Vice President of Investor Relations and Treasury at Neogen Corporation. He previously held CFO roles at LarmorBio and NX Prenatal, served as interim CFO at OraSure Technologies, and led corporate strategy and investor relations at Myriad Genetics. He holds a B.S. in Economics from the United States Air Force Academy.&lt;/p&gt;

&lt;p&gt;&quot;Scott brings financial leadership, operating discipline, and capital markets</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Sera+Prognostics+names+Scott+Gleason+as+CFO%2C+effective+Aug.+31/26950481.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:17 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER</title>
   <link>http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ut.sltlkc&quot; idsrc=&quot;xmltag.org&quot; &gt;SALT LAKE CITY&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 19, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4755748-1&amp;amp;h=45414742&amp;amp;u=https%3A%2F%2Fwww.sera.com%2F&amp;amp;a=Sera+Prognostics+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-NMS:SERA&quot; idsrc=&quot;xmltag.org&quot; &gt;Sera Prognostics Inc.&lt;/span&gt;&lt;/a&gt;, &lt;span&gt;The Pregnancy Company&lt;/span&gt;&lt;sup&gt;®&lt;/sup&gt; (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced today that &lt;person&gt;Scott Gleason&lt;/person&gt; has been appointed Chief Financial Officer (CFO), effective &lt;chron&gt;August 31, 2026&lt;/chron&gt;.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/SERA+PROGNOSTICS+APPOINTS+SCOTT+GLEASON+CHIEF+FINANCIAL+OFFICER/26950473.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216925</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56784295</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Sera Prognostics (SERA) Misses Q2 EPS by 3c</title>
   <link>http://www.streetinsider.com/Earnings/Sera+Prognostics+%28SERA%29+Misses+Q2+EPS+by+3c/26913844.html</link>
   <description>&lt;p&gt;Sera Prognostics (NASDAQ: SERA) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $63.88 thousand.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Sera Prognostics (SERA) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=SERA&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Sera+Prognostics+%28SERA%29+Misses+Q2+EPS+by+3c/26913844.html</guid>
   <pubDate>Wed, 12 Aug 2026 16:49:56 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Form  10-Q       SERA PROGNOSTICS, INC.    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Jun+30/26912957.html</link>
   <description>si-local-file:///var/storage/secattach/20260812/26912957.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Jun+30/26912957.html</guid>
   <pubDate>Wed, 12 Aug 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
  <item>
   <title>Form  10-Q       SERA PROGNOSTICS, INC.    For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Jun+30/26912957.html</link>
   <description>si-local-file:///var/storage/secattach/20260812/26912957.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++SERA+PROGNOSTICS%2C+INC.++++For%3A+Jun+30/26912957.html</guid>
   <pubDate>Wed, 12 Aug 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.08518578</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SERA</category>
   	  </item>
 </channel>
</rss>
